A phase II study of Temsirolimus in patients with advanced hormone - and chemotherapy - resistant prostate cancer.
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2017
At a glance
- Drugs Temsirolimus (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 28 Apr 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 06 Oct 2011 New trial record